Human iPSC-Based Modeling of Late-Onset Disease via Progerin-Induced Aging

Cited by (781)

Items 401–500 of 781

  1. Integrating population genetics, stem cell biology and cellular genomics to study complex human diseases
    Nona Farbehi, Drew R. Neavin, Anna S. E. Cuomo, Lorenz Studer, Daniel G. MacArthur, Joseph E. Powell · 2024 · Nature Genetics
  2. Pluripotent stem cells to model Hutchinson-Gilford progeria syndrome (HGPS): Current trends and future perspectives for drug discovery
    Alessandra Lo Cicero, Xavier Nissan · 2015 · Ageing Research Reviews
  3. The translational potential of human induced pluripotent stem cells for clinical neurology
    Helen E. Devine, Rickie Patani · 2016 · Cell Biology and Toxicology
  4. Age-Related Epigenetic Derangement upon Reprogramming and Differentiation of Cells from the Elderly
    Francesco Ravaioli, Maria Giulia Bacalini, Claudio Franceschi, Paolo Garagnani · 2018 · Genes
  5. Modelling mitochondrial dysfunction in Alzheimer's disease using human induced pluripotent stem cells
    Kate Hawkins, Michael R. Duchen · 2019 · World Journal of Stem Cells
  6. Cell Reprogramming to Model Huntington’s Disease: A Comprehensive Review
    Ruth Monk, Bronwen J. Connor · 2021 · Cells
  7. Improving the repopulation capacity of elderly human hepatocytes by decoding aging‐associated hepatocyte plasticity
    Yunzhong Nie, Yun‐Wen Zheng, Hideki Taniguchi · 2022 · Hepatology
  8. Cellular Models of Aging and Senescence
    Kim, Byunggik, Lee, Dong I., Basisty, Nathan, Dai, Dao-Fu · 2025 · Cells
  9. Pluripotent stem cell-derived models of neurological diseases reveal early transcriptional heterogeneity
    Matan Sorek, Walaa Oweis, Malka Nissim‐Rafinia, Moria Maman, Shahar Simon, Cynthia C. Hession, Xian Adiconis, Sean Simmons, Neville E. Sanjana, Xi Shi et al. · 2021 · Genome biology
  10. Human stem cell transplantation models of Alzheimer’s disease
    Nkechime Ifediora, Peter Canoll, Gunnar Hargus · 2024 · Frontiers in Aging Neuroscience
  11. Changes in Action Tremor in Parkinson's Disease over Time: Clinical and Neuroimaging Correlates
    Kevin R.E. van den Berg, Martin E. Johansson, Michiel F. Dirkx, Bastiaan R. Bloem, Rick C. G. Helmich · 2024 · Movement Disorders
  12. Solving the puzzle of Parkinson’s disease using induced pluripotent stem cells
    Ping Zhao, Zhiwei Luo, Weihua Tian, Jiayin Yang, David P. Ibañez, Zhijian Huang, Micky Daniel Tortorella, Miguel Angel Esteban, Wenxia Fan · 2014 · Experimental Biology and Medicine
  13. The use of human neurons for novel drug discovery in dementia research
    Mariana Vargas‐Caballero, Sandrine Willaime‐Morawek, Diego Gómez‐Nicola, Victor Hugh Perry, Diederik Olivier Bulters, Amritpal K. Mudher · 2016 · Expert Opinion on Drug Discovery
  14. ALS, a cellular whodunit on motor neuron degeneration
    Peter Karagiannis, Haruhisa Inoue · 2020 · Molecular and Cellular Neuroscience
  15. Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology
    Rebekka Kühn, Aayushi Mahajan, Peter Canoll, Gunnar Hargus · 2021 · Frontiers in Cell and Developmental Biology
  16. Patient-Specific iPSCs-Based Models of Neurodegenerative Diseases: Focus on Aberrant Calcium Signaling
    Dmitriy A. Grekhnev, Elena V. Kaznacheyeva, Vladimir A. Vigont · 2022 · International Journal of Molecular Sciences
  17. Studying human disease using human neurons
    Tim Ahfeldt, Nadia K. Litterman, Lee L. Rubin · 2016 · Brain Research
  18. Evolving principles underlying neural lineage conversion and their relevance for biomedical translation
    Lea Jessica Flitsch, Oliver Brüstle · 2019 · F1000Research
  19. Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls
    Stanislav Tsitkov, Kelsey Valentine, Velina Kozareva, Aneesh Donde, Aaron P. Frank, Susan Lei, Michael J. Workman, Ryan G. Lim, Jie Wu, Zhuoxing Wu et al. · 2024 · Nature Communications
  20. Chimeric brain models: Unlocking insights into human neural development, aging, diseases, and cell therapies
    Ava V. Papetti, Mengmeng Jin, Ziyuan Ma, Alessandro C. Stillitano, Peng Jiang · 2025 · Neuron
  21. Proceedings: Consideration of Genetics in the Design of Induced Pluripotent Stem Cell-Based Models of Complex Disease
    Uta Grieshammer, Kelly A. Shepard · 2014 · Stem Cells Translational Medicine
  22. Neurodegeneration in a dish: advancing human stem-cell-based models of Alzheimer’s disease
    Julien Klimmt, Angelika Dannert, Dominik Paquet · 2020 · Current Opinion in Neurobiology
  23. Reprogramming iPSCs to study age-related diseases: Models, therapeutics, and clinical trials
    Filipa Esteves, David V.C. Brito, Ana Teresa Rajado, Nádia Silva, Joana Dias Apolónio, Vânia Palma Roberto, Inês M. Araújo, Clévio Nóbrega, Pedro Castelo‐Branco, José Bragança et al. · 2023 · Mechanisms of Ageing and Development
  24. Progerin expression induces a significant downregulation of transcription from human repetitive sequences in iPSC-derived dopaminergic neurons
    Walter Arancio · 2019 · GeroScience
  25. Using Induced Pluripotent Stem Cells to Explore Genetic and Epigenetic Variation Associated With Alzheimer’S Disease
    Jennifer L. Imm, Talitha L. Kerrigan, Aaron R. Jeffries, Katie Lunnon · 2017 · Epigenomics
  26. Human iPSC-Derived Neurons as A Platform for Deciphering the Mechanisms behind Brain Aging
    Chuan‐Chuan Chao, Po-Wen Shen, Tsai‐Yu Tzeng, Hsing‐Jien Kung, Ting‐Fen Tsai, Yu‐Hui Wong · 2021 · Biomedicines
  27. Central nervous system organoids for modeling neurodegenerative diseases
    Pei‐Shan Hou, Hung‐Chih Kuo · 2022 · IUBMB Life
  28. Antisense Oligonucleotide Induction of Progerin in Human Myogenic Cells
    Yue‐Bei Luo, Chalermchai Mitrpant, Abbie M. Adams, Russell D. Johnsen, Sue Fletcher, Frank Louis Mastaglia, Steve Donald Wilton · 2014 · PLoS ONE
  29. Differential Expression of Inflammasome-Related Genes in Induced Pluripotent Stem-Cell-Derived Retinal Pigment Epithelial Cells with or without History of Age-Related Macular Degeneration
    Maria Hytti, Eveliina Korhonen, Heidi Hongisto, Kai Kaarniranta, Heli Skottman, Anu Kauppinen · 2021 · International Journal of Molecular Sciences
  30. Directly Reprogrammed Human Neurons to Understand Age‐Related Energy Metabolism Impairment and Mitochondrial Dysfunction in Healthy Aging and Neurodegeneration
    Camila Gudenschwager, Isadora Chavez, César Cárdenas, Christian Enrique González-Billault · 2021 · Oxidative Medicine and Cellular Longevity
  31. Role of Telomeres and Telomerase in Parkinson's Disease—A New Theranostics?
    Balachandar Vellingiri, Kiruthika Balasubramani, Mahalaxmi Iyer, Neethu Raj, Ajay Elangovan, Kwonwoo Song, Han Cheol Yeo, Namitha Jayakumar, Masako Kinoshita, Thangarasu Ravimanickam et al. · 2023 · Advanced Biology
  32. Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative Diseases
    Shripriya Singh, Akriti Srivastava, Pranay Srivastava, Yogesh Kumar Dhuriya, Ankita Pandey, Dipak Kumar, Chetan Singh Rajpurohit · 2016 · Frontiers in Molecular Biosciences
  33. Induced Pluripotent Stem Cells: Global Research Trends
    Takaharu Negoro, Hanayuki Okura, Akifumi Matsuyama · 2017 · BioResearch open access
  34. Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Niemann-Pick Type C1
    Christin Völkner, Maik Liedtke, Andreas Hermann, Moritz J. Frech · 2021 · International Journal of Molecular Sciences
  35. Making Sense of Patient-Derived iPSCs, Transdifferentiated Neurons, Olfactory Neuronal Cells, and Cerebral Organoids as Models for Psychiatric Disorders
    Jakob Unterholzner, Vincent Millischer, Christoph Wotawa, Akira Sawa, Rupert R. Lanzenberger · 2021 · The International Journal of Neuropsychopharmacology
  36. The future of Parkinson’s disease research: A new paradigm of human-specific investigation is necessary… and possible
    Manuela Cassotta · 2022 · ALTEX
  37. Aging in iPS cells
    Justine D. Miller, Lorenz Studer · 2014 · Aging
  38. Protocol Optimization for Direct Reprogramming of Primary Human Fibroblast into Induced Striatal Neurons
    Nina Kraskovskaya, Anastasia V. Bolshakova, Хотин Михаил Георгиевич, Безпрозванный Илья Борисович, Natalia Mikhailova · 2023 · International Journal of Molecular Sciences
  39. Midbrain organoids—development and applications in Parkinson’s disease
    Hilary S. Y. Toh, Xin Yi Choo, Alfred Xuyang Sun · 2023 · Oxford Open Neuroscience
  40. Dynamic neuro-immune regulation of psychiatric risk loci in human neurons
    Kayla G. Townsley, S. H. Lee, Sarah Williams, Sam Cartwright, Sophie Cohen, Annabel Sen, Meng Jia, Hannah E. Young, Lee Dobbyn, Michael Deans et al. · 2026 · Nature Communications
  41. Human pluripotent stem cells on artificial microenvironments: a high content perspective
    Priyalakshmi Viswanathan, Terri L. Gaskell, Nathalie Moens, Oliver J. Culley, Darrick M. Hansen, Mia K. R. Gervasio, Yee Jie Yeap, Davide Danovi · 2014 · Frontiers in Pharmacology
  42. Patient-specific pluripotent stem cell-based Parkinson’s disease models showing endogenous alpha-synuclein aggregation
    Yohan Oh · 2019 · BMB Reports
  43. From Cell Culture to Organoids-Model Systems for Investigating Prion Strain Characteristics
    Hailey Pineau, Valerie L. Sim · 2021 · Biomolecules
  44. Modular deep learning enables automated identification of monoclonal cell lines
    Brodie Fischbacher, Sarita Hedaya, Brigham J. Hartley, Zhongwei Wang, Gregory Lallos, Dillion Hutson, Matthew Zimmer, Jacob Brammer, The NYSCF Global Stem Cell Array Team,, Daniel J Paull · 2021 · Nature Machine Intelligence
  45. Transcriptomic reprogramming for neuronal age reversal
    Alexandru M. Pleşa, Michael Shadpour, Edward S. Boyden, George McDonald Church · 2023 · Human Genetics
  46. Senescence, regulators of alternative splicing and effects of trametinib treatment in progeroid syndromes
    Laura R. Bramwell, Lorna W. Harries · 2023 · GeroScience
  47. Connectivity and circuitry in a dish versus in a brain
    Vorapin Chinchalongporn, Peter Koppensteiner, Deborah Prè, Wipawan Thangnipon, Leonilda Bilo, Ottavio Arancio · 2015 · Alzheimer s Research & Therapy
  48. Opportunities and Limitations of Modelling Alzheimer’s Disease with Induced Pluripotent Stem Cells
    Dmitry A. Ovchinnikov, Ernst Jurgen Wolvetang · 2014 · Journal of Clinical Medicine
  49. Engineering human cells and tissues through pluripotent stem cells
    Jeffrey R. Jones, Su‐Chun Zhang · 2016 · Current Opinion in Biotechnology
  50. Hydroxyurea Facilitates Manifestation of Disease Relevant Phenotypes in Patients-Derived IPSCs-Based Modeling of Late-Onset Parkinson’s Disease
    Yuan Tan, Minjing Ke, Zhijian Huang, Cheong‐Meng Chong, Xiaotong Cen, Jiahong Lu, Xiaoli Yao, Dajiang Qin, Huanxing Su · 2019 · Aging and Disease
  51. Inducing Cellular Aging: Enabling Neurodegeneration-in-a-Dish
    Kristen Brennand · 2013 · Cell stem cell
  52. Interspecies Organoids Reveal Human-Specific Molecular Features of Dopaminergic Neuron Development and Vulnerability
    Sara Nolbrant, Jenelle L. Wallace, Jingwen Ding, Tianjia Zhu, Jessica L. Sevetson, Janko Kajtez, Isabella A. Baldacci, Emily K. Corrigan, Kaylynn Hoglin, Reed McMullen et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  53. Modeling neurodegenerative diseases with brain organoids: from development to disease applications
    Teresa Larriba-González, Marina García-Martín, Doddy Denise Ojeda-Hernández, Paula Rincón-Cerrada, Lucía Martín-Blanco, María Soledad Benito‐Martín, Belén Selma-Calvo, Sarah de la Fuente-Martín, Jordi A. Matías‐Guiu, Jorge Matías‐Guiu et al. · 2025 · Frontiers in Cell and Developmental Biology
  54. Epigenetics of cell fate reprogramming and its implications for neurological disorders modelling
    Maciej Grzybek, Aleksandra Golonko, Marta Walczak, Paweł Lisowski · 2016 · Neurobiology of Disease
  55. Generation of human midbrain organoids from induced pluripotent stem cells
    Nguyen‐Vi Mohamed, Meghna Mathur, Ronan V. da Silva, Rhalena A. Thomas, Paula Lépine, Thomas M. Durcan, Edward A. Fon, Thomas M. Durcan · 2019 · MNI Open Research
  56. Rag2−/− accelerates lipofuscin accumulation in the brain: Implications for human stem cell brain transplantation studies
    Mengmeng Jin, Mahabub Maraj Alam, Alice Y.‐C. Liu, Peng Jiang · 2022 · Stem Cell Reports
  57. Generation of dopamine neuronal-like cells from induced neural precursors derived from adult human cells by non-viral expression of lineage factors
    Rebecca Playne, Kathryn Jones, Bronwen J. Connor · 2018 · Journal of Stem Cells and Regenerative Medicine
  58. Contribution of Human Pluripotent Stem Cell-Based Models to Drug Discovery for Neurological Disorders
    Alexandra Benchoua, Marie Lasbareilles, Johana Tournois · 2021 · Cells
  59. Mice that express farnesylated versions of prelamin A in neurons develop achalasia
    Shao Hua Yang, Shiri Procaccia, Hea-Jin Jung, Chika Nobumori, Angelica Tatar, Yiping Tu, Yulia R. Bayguinov, Sung Jin Hwang, Deanna Tran, Sean M. Ward et al. · 2015 · Human Molecular Genetics
  60. GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tau
    Acosta Ingram, Diana, Turkes, Emir, Kim, Tae Yeon, Vo, Sheeny, Sweeney, Nicholas, Bonte, Marie-Amandine, Rutherford, Ryan, Julian, Dominic L., Pan, Meixia, Marsh, Jacob et al. · 2025 · Nature Communications
  61. Concise Review: The Epigenetic Contribution to Stem Cell Ageing: Can We Rejuvenate Our Older Cells?
    Lyle Armstrong, Jumana Yousuf Al-Aama, Miodrag Stojković, Majlinda Lako · 2014 · Stem Cells
  62. Dementia in a Dish
    Claudia A. Doege, Asa Abeliovich · 2014 · Biological Psychiatry
  63. Cell Reprogramming Preserving Epigenetic Age: Advantages and Limitations
    E. M Samoylova, Vladimir P. Baklaushev · 2020 · Biochemistry (Moscow)
  64. Phenotyping Neurodegeneration in Human iPSCs
    Jonathan Li, Ernest Fraenkel · 2021 · Annual Review of Biomedical Data Science
  65. Motor neuron-derived induced pluripotent stem cells as a drug screening platform for amyotrophic lateral sclerosis
    Mariana A. Amorós, Esther Sue Choi, Axel Helmut Rulf Cofré, Nikolay V. Dokholyan, Marcelo Duzzioni · 2022 · Frontiers in Cell and Developmental Biology
  66. Stem cell therapy in neurological disorders: promises and concerns
    Saı̈d Hachimi-Idrissi · 2023 · Exploration of Neuroprotective Therapy
  67. Quo vadis motor neuron disease?
    Rubika Balendra, Rickie Patani · 2016 · World Journal of Methodology
  68. Stem Cell Engineering and Differentiation for Disease Modeling and Cell-based Therapies
    Lauren N. Randolph, Yuqian Jiang, Xiaojun Lance Lian, § These authors contributed equally. · 2017 · AIMS Cell and Tissue Engineering
  69. Investigating pediatric disorders with induced pluripotent stem cells
    Matthew D. Durbin, Adrian Gabriel Cadar, Young Wook Chun, Charles C. Hong · 2018 · Pediatric Research
  70. Modeling Parkinson’s Disease and Atypical Parkinsonian Syndromes Using Induced Pluripotent Stem Cells
    Takayasu Mishima, Shinsuke Fujioka, Jiro Fukae, Junichi Yuasa‐Kawada, Yoshio Tsuboi · 2018 · International Journal of Molecular Sciences
  71. Progress in understanding Friedreich’s ataxia using human induced pluripotent stem cells
    Anna Maria Schreiber, Julia Oliwia Misiorek, Jill S. Napierala, Марек Напиерала · 2018 · Expert Opinion on Orphan Drugs
  72. Disease Modeling of Neuropsychiatric Brain Disorders Using Human Stem Cell-Based Neural Models
    Johanna Kaindl, Beate Winner · 2019 · Current topics in behavioral neurosciences
  73. Identifying Age‐Modulating Compounds Using a Novel Computational Framework for Evaluating Transcriptional Age
    Chao Zhang, Nathalie G. Saurat, Daniela Cornacchia, Sun Young Chung, Trisha Sikder, Adrianne Nemchik, Andrew P. Minotti, Lorenz Studer, Doron Betel · 2025 · Aging Cell
  74. Review: Induced pluripotent stem cell models of frontotemporal dementia
    Elisavet Preza, John Hardy, Thomas T. Warner, Selina Wray · 2016 · Neuropathology and Applied Neurobiology
  75. Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer’s Disease
    Jessica E. Young, Lawrence S.B. Goldstein · 2022 · Methods in molecular biology
  76. Aging, Parkinson’s Disease, and Models: What Are the Challenges?
    Ilaria Bellantuono, Heather Mortiboys, Emily M. Rocha, Manish Chamoli, Shankar J. Chinta, Julie Kay Andersen, Ruby Wallis, Erwan Bézard, Matt Goldberg, Tim Greenamyre et al. · 2023
  77. Rapid and high-purity differentiation of human medium spiny neurons reveals LMNB1 hypofunction and subtype necessity in modeling Huntington’s disease
    Junjiao Wu, Jie Ren, Hongfei Cui, Yali Xie, Yu Tang · 2024 · Inflammation and Regeneration
  78. Expression of Nuclear Lamin Proteins in Endothelial Cells is Sensitive to Cell Passage and Fluid Shear Stress
    Yizhi Jiang, Julie Y. Ji · 2017 · Cellular and Molecular Bioengineering
  79. Cellular Models: HD Patient-Derived Pluripotent Stem Cells
    Charlene Smith-Geater, Sarah J. Hernandez, Leslie Michels Thompson, Virginia B. Mattis · 2018 · Methods in molecular biology
  80. Unraveling pathological mechanisms in neurological disorders: the impact of cell-based and organoid models
    Jake A. Langlie, Rahul Mittal, Ariel Finberg, Nathalie B. Bencie, Jeenu Mittal, Hossein Omidian, Yadollah Omidi, Adrien A. Eshraghi · 2022 · Neural Regeneration Research
  81. Induced pluripotent stem cells and neurological disease models.
    Sa Cai, Ying-Shing Chan, Daisy Kwok-Yan Shum · 2014 · PubMed
  82. Stem Cell Models: A Guide to Understand and Mitigate Aging?
    Regina Brunauer, Silvestre Alavez, Brian Keith Kennedy · 2016 · Gerontology
  83. Interpreting Gene Expression Effects of Disease-Associated Variants: A Lesson from SNCA rs356168
    Omolara-Chinue Glenn, Lidia Tagliafierro, Thomas G. Beach, Randy L Woltjer, Ornit Chiba‐Falek · 2017 · Frontiers in Genetics
  84. Modeling Leukemia with Human Induced Pluripotent Stem Cells
    Eirini P. Papapetrou · 2019 · Cold Spring Harbor Perspectives in Medicine
  85. WITHDRAWN: Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective
    Pierre Cau, Claire Laure Navarro, Karim Harhouri, Patrice Roll, Sabine Sigaudy, Élise Kaspi, Sophie Perrin, Annachiara De Sandre‐Giovannoli, Nicolas Lévy · 2014 · Seminars in Cell and Developmental Biology
  86. Klotho overexpression protects human cortical neurons from β-amyloid induced neuronal toxicity
    Mohammed R. Shaker, Salam Salloum‐Asfar, Rowaida Ziad Taha, Ibrahim Javed, Ernst Jurgen Wolvetang · 2025 · Molecular Brain
  87. Reprogramming of somatic cells
    Vania Broccoli · 2017 · Progress in brain research
  88. Building in vitro models of the brain to understand the role ofAPOEin Alzheimer’s disease
    Rebecca L. Pinals, Li‐Huei Tsai · 2022 · Life Science Alliance
  89. Functional bioengineered tissue models of neurodegenerative diseases
    Adam S. Mullis, David Lee Kaplan · 2023 · Biomaterials
  90. Cell and tissue reprogramming: Unlocking a new era in medical drug discovery
    Chandan K. Sen, Andrew J. Friday, Sashwati Roy · 2025 · Pharmacological Reviews
  91. In search of lost time: age and the promise of induced pluripotent stem cell models of the brain
    Richard Milne · 2016 · New Genetics and Society
  92. Short Review: Investigating ARSACS: models for understanding cerebellar degeneration
    Ana Artero‐Castro, Candela Machuca, F. J. Rodriguez Jimenez, Pavla Jendelová, Slaven Erceg · 2019 · Neuropathology and Applied Neurobiology
  93. Epigenetic Analysis in Human Neurons: Considerations for Disease Modeling in PD
    Laura de Boni, Ullrich Wüllner · 2019 · Frontiers in Neuroscience
  94. Live Viral Vaccine Neurovirulence Screening: Current and Future Models
    Corey May Fulton, Wendy J. Bailey · 2021 · Vaccines
  95. Modeling and Targeting Neuroglial Interactions with Human Pluripotent Stem Cell Models
    Julie Bigarreau, Nathalie Rouach, Anselme L. Perrier, Franck Mouthon, Mathieu Charvériat · 2022 · International Journal of Molecular Sciences
  96. Modelling neurodegenerative diseases in vitro: Recent advances in 3D iPSC technologies
    Elodie J. Siney, Ksenia Kurbatskaya, Shreyasi Chatterjee, Preeti Prasannan, Amritpal K. Mudher, Sandrine Willaime‐Morawek · 2018 · AIMS Cell and Tissue Engineering
  97. The Role of BMI1 in Late-Onset Sporadic Alzheimer’s Disease
    Ryan Hogan, Anthony Flamier, Eleonora Nardini, Gilbert Bernier · 2020 · Genes
  98. Human induced pluripotent stem cell-derived myotubes to model inclusion body myositis
    Judith Cantó, Laura Valls‐Roca, Ester Tobías, Francesc Josep García‐García, Mariona Guitart‐Mampel, Félix Andújar-Sánchez, Adrià Vilaseca-Capel, Anna Esteve‐Codina, Beatriz Martín‐Mur, Joan Padrosa et al. · 2025 · Acta Neuropathologica Communications
  99. Application of human iPSC-derived white, beige, and brown adipocytes for metabolic disease modeling and transplantation therapy
    Yamato Keidai, Junji Fujikura, Daisuke Yabe · 2025 · Cell Transplantation
  100. Human neural progenitors establish a diffusion barrier in the endoplasmic reticulum membrane during cell division
    Muhammad Khadeesh bin Imtiaz, Lars N. Royall, Daniel Gonzalez-Bohorquez, Sebastian Jessberger · 2022 · Development